The First

The Best

The Frontier of Early Cancer Dx

Innovating MDx with IPs

HeimBiotek developed a highly accurate molecular diagnostic technique for diagnosis of early to late-stage cancer with liquid biopsy using whole blood, urine etc. based on miRNA detection and analysis technology, ahead of its commercialization.

Edit Template



R&D Initiatives & Advancement

For Global Leadership in MDx

Driving R&D and Innovation to address the unmet needs of Liquid Biopsy Cancer Diagnostics, starting with Liver Cancer.

Edit Template


miRNA Biomarker

Next-Generation Biomarker for Early Dx Introducing an innovative diagnostic method for Cancer, Encephalopathy, Cardiovascular Diseases etc.

miRNA Detection

Detection and analysis technique to quantify miRNA using Real-Time PCR that demonstrates high sensitivity and accuracy.